| Brenda L Jones, LPN | |
|
2141 Oregon Pike, Lancaster, PA 17601 | |
| (717) 560-7917 | |
| (717) 560-6452 |
| Full Name | Brenda L Jones |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2141 Oregon Pike, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003938358 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN089484L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brenda L Jones, LPN 2141 Oregon Pike, Lancaster, PA 17601 Ph: (717) 560-7917 | Brenda L Jones, LPN 2141 Oregon Pike, Lancaster, PA 17601 Ph: (717) 560-7917 |
News Archive
Over 1 billion people globally are affected by iron-deficiency anemia. In sub-Saharan Africa, anemia is a major public health concern with roughly 60% of the population suffering from anemia.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
At today's ribbon cutting ceremony, The Center for Pediatric Dentistry, created to address the growing epidemic of childhood dental disease, announced the grand opening of its facility on September 1, 2010. The Seattle-based institute is the first of its kind in the country, providing pediatric dental care, education for dentists and medical professionals, research, and policy under one roof.
The following release is being issued by law firms RodaNast, P.C.; Levin, Fishbein, Sedran & Berman and Feldman & Pinto: According to two new studies published in the online edition of the British Medical Journal, Bayer's birth control pills Yaz and Yasmin, containing a new progestin drospirenone, carry up to triple the risk of serious blood clots over traditional pills containing the progestin levonorgestrel.
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
› Verified 6 days ago
Meggin Hughes, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2141 Oregon Pike, Lancaster, PA 17601 Phone: 717-617-2706 | |
Mishia Brown, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2141 Oregon Pike, Lancaster, PA 17601 Phone: 717-617-2706 | |
Reina Rivera, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2141 Oregon Pike, Lancaster, PA 17602 Phone: 717-617-2708 | |
Aniyah Stephens, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2141 Oregon Pike, Lancaster, PA 17601 Phone: 717-617-2706 | |
Nohely Rosario, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 790 New Holland Ave, Lancaster, PA 17602 Phone: 717-293-5104 Fax: 717-390-1812 | |
Ashley Mason, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2141 Oregon Pike, Lancaster, PA 17602 Phone: 717-617-2708 |